Cited by 72Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research AdvancesRenal cell carcinoma treatment

Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study

Open access
Buitenwerf, Edward, Korteweg, Tijmen, Visser, Anneke, Haag, Charlotte M S C, Feelders, Richard A, Timmers, Henri J L M, Canu, Letizia, Haak, Harm R +11 more·2018·European Journal of Endocrinology

Abstract

BACKGROUND: A substantial proportion of all pheochromocytomas is currently detected during the evaluation of an adrenal incidentaloma. Recently, it has been suggested that biochemical testing to rule out pheochromocytoma is unnecessary in case of an adrenal incidentaloma with an unenhanced attenuation value ≤10 Hounsfield Units (HU) at computed tomography (CT). OBJECTIVES: We aimed to determine the sensitivity of the 10 HU threshold value to exclude a pheochromocytoma. METHODS: Retrospective multicenter study with systematic reassessment of preoperative unenhanced CT scans performed in patients in whom a histopathologically proven pheochromocytoma had been diagnosed. Unenhanced attenuation values were determined independently by two experienced radiologists. Sensitivity of the 10 HU threshold was calculated, and interobserver consistency was assessed using the intraclass correlation coefficient (ICC). RESULTS: 214 patients were identified harboring a total number of 222 pheochromocytomas. Maximum tumor diameter was 51 (39-74) mm. The mean attenuation value within the region of interest was 36 ± 10 HU. Only one pheochromocytoma demonstrated an attenuation value ≤10 HU, resulting in a sensitivity of 99.6% (95% CI: 97.5-99.9). ICC was 0.81 (95% CI: 0.75-0.86) with a standard error of measurement of 7.3 HU between observers. CONCLUSION: The likelihood of a pheochromocytoma with an unenhanced attenuation value ≤10 HU on CT is very low. The interobserver consistency in attenuation measurement is excellent. Our study supports the recommendation that in patients with an adrenal incidentaloma biochemical testing for ruling out pheochromocytoma is only indicated in adrenal tumors with an unenhanced attenuation value >10 HU.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-18-0006

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mean Hounsfield unit scores for pheochromocytoma are 30 to 35, with only 0.5% of pheochromocytomas having an unenhanced CT attenuation of 10 HU or less.

    “Mean HU scores for pheochromocytoma are 30 to 35 (197) with only 0.5% of pheochromocytoma having an unenhanced CT attenuation of ≤10 HU (97,197,198).”

    From Adrenal incidentaloma (2020) · cites this paper as [197]

  • Buitenwerf et al. reviewed CT images of 222 histologically proven pheochromocytomas, yielding only a single tumor with an unenhanced attenuation of less than 10 HU.

    “Buitenwerf et al. (197) reviewed the CT images of 222 histologically proven pheochromocytomas, yielding only a single tumor with an unenhanced attenuation of <10 HU.”

    From Adrenal incidentaloma (2020) · cites this paper as [197]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 27 · Cited by 72

Research works printed but not linked: 1

  1. DeLellis R, Heitz P & Eng C. Pathology and Genetics: Tumours of Endocrine Organs (IARC WHO Classification of Tumours). Lyon, France: IARC Press, 2004.

Authors
Buitenwerf, E., Korteweg, T., Visser, A., Haag, C. M. S. C., Feelders, R. A., Timmers, H. J. L. M., Canu, L., Haak, H. R., Bisschop, P. H. L. T., Eekhoff, E. M. W., Corssmit, E. P. M., Krak, N. C., Rasenberg, E., van den Bergh, J., Stoker, J., Greuter, M. J. W., Dullaart, R. P. F., Links, T. P., & Kerstens, M. N.
Affiliations
  • University Medical Center Groningen (NL)
  • Erasmus MC (NL)
  • Radboud University Medical Center (NL)
  • Maastricht University Medical Centre (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Leiden University Medical Center (NL)
  • Máxima Medisch Centrum (NL)
  • 14Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands
Corresponding author
Buitenwerf, Edward
Venue
European Journal of Endocrinology
Published
2018-05
Volume
178
Issue
5
Pages
431-437
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2788731763
Cited by
72
References
27
Citations by year
2026: 6 · 2025: 10 · 2024: 9 · 2023: 11 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 9 · 2018: 4
FWCI
7.02
Type
journal article
Language
en
Open access
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Florence Research (University of Florence) (submittedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Renal cell carcinoma treatment
Keywords
pheochromocytoma, adrenal incidentaloma, diagnostic sensitivity, biochemical tests, interobserver agreement, adrenal tumors
MeSH terms
Academic Medical Centers, Adrenal Gland Neoplasms, Adrenal Glands, Adult, Aged, Diagnosis, Differential, False Negative Reactions, Female, Hospitals, Teaching, Humans, Male, Middle Aged, Netherlands, Pheochromocytoma, Retrospective Studies, Sensitivity and Specificity, Tomography, X-Ray Computed, Observer Variation, Tumor Burden

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review